new weight loss drug retatrutide (“reta”) is an experimental weight-loss currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works The Retatrutide Dosage Chart

Nobody wants to be obese, just like nobody wants to have erectile dysfunction, the hedonic desire to look good is something that should be factored in here

That being said, Dr

412 (2010): 1834, 10.1016/j.brainres.2010.03.059

M., Tiano, J

Diabetes is associated with an increased risk of developing dementia and neurodegenerative diseases, which is inversely related to the degree of glucose tolerance and directly to the disease duration [16]

Acknowledgements The authors would like to thank Henrik Kim Nielsen, Jens Heisterberg, and Karen Hauda (Novo Nordisk A/S, Denmark), and Gina MacNeil (Novo Nordisk Inc, United States) for review of, and input to, the manuscript, as well as Tina stergaard, Sisse Lakner Schmidt, and Michala Cronberg (Novo Nordisk A/S, Denmark) for help with physical stability analyses